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J.-M. De Conto, ISN (CNRS/IN2P3-UJF), Grenoble, France 
on behalf of the technical study group (CEA/DSM/DAPNIA, CNRS/IN2P3, UCBL)
Abstract 
The Université Claude Bernard Lyon 1 (UCBL) took 
the initiative in 1999 to ask a number of French doctors 
and physicists to draw up a specification for the creation 
of a Light Ion Hadrontherapy Centre. Under the auspices 
of this university and with the support of the local 
authorities and the Ministry of Research, a preliminary 
design [1] has been made in collaboration between 
UCBL, Commissariat à lEnergie Atomique (CEA/DSM) 
and Centre National de la Recherche Scientifique 
(CNRS/IN2P3). This project has taken full account of the 
experimental work carried out in Germany and Japan, and 
is part of a coordinated European approach, with similar 
projects developed in Austria, Germany, Italy and Sweden 
(ENLIGHT network).  
1 INTRODUCTION 
Light ion hadrontherapy has been tested in Japan 
(Chiba) and Germany (Darmstadt) for several years, 
following the pioneering work initially carried out at 
Berkeley. This method, which requires heavy-duty 
equipment, has demonstrated the advantages of these 
ions, in particular carbon ions, for the very accurate 
treatment of deep-seated tumours which are inoperable 
and radioresistant. ETOILE will be able to cure more than 
500 of the 1000 patients treated each year (for whom 
existing treatments would have little effect), with a 
treatment cost lower than other cancer therapies currently 
in use. 
The synchrotron is the kind of accelerator which best 
meets the medical specifications. Associated to the 
rasterscan technique developed and successfully applied 
at GSI, it permits to treat tumours with a complex shape, 
with a high flexibility: choice of energy/intensity of each 
spill in a wide range, spill triggering for mobile tumours, 
three-dimensional conformal irradiation. The optical 
structure of such an accelerator may be based on various 
types of solutions (lattice, injection, extraction) and 
requires a considerable amount of work. Such a task has 
been undertaken at CERN from 1996 to 1999 (PIMMS 
project) [2] before the start of ETOILE, leading to the 
detailed design of an optimized instrument. Following the 
Italian (CNA), Austrian (Med-Austron) and Swedish 
(Stockholm) projects, the PIMMS synchrotron has been 
adopted. 
More generally, ETOILE has been designed by looking 
for common concepts and elements with the other 
European projects. The various elements (accelerator, 
beam distribution, building) have been examined to a 
detailed stage. The design is based on the most advanced 
projects (Italy, Germany) [3][4], on the actual experience 
of GSI and Orsay, and on the expertise of the research 
organizations (CEA, CERN, CNRS). Specific studies 
have been carried out (injection in the synchrotron, beam 
distribution, command/control, building, infrastructure, 
cost, staff and planning). 
 
Table 1: Medical requirements 
Ions 12C6+ and protons  
(possibility from p to 16O) 
Penetration 2 to 27 cm in water 
Max. dose rate 2 Gy in 1 minute for 1 litre 
Irradiation rasterscanning 
Treatment 
rooms 
3 (2 with fixed horizontal beam, 1 
with fixed vertical beam or gantry) 
Patients  1000 patients /year 
Operation 15 sessions/patient 0.5 hour/session 
220 working days/year, 11 hours/day 
 
Table 2: Technical specifications 
Sources 2 ECR sources 
Injector RFQ+linac (GSI/Heidelberg) 
Main accelerator Synchrotron (PIMMS) 
Distribution Fish-bone structure 
Energies 85-400 MeV/amu for carbon 
50-200 MeV for protons 
Extraction time 0.2  4 seconds 
Nb of particles at 
patient, per spill 
4x108 for 12C6+ 
1010 for protons 
Cycle duration 1-10 seconds (gating) 
Beam size 4-10 mm at patient (FWHM) 
 
2 LAYOUT OF THE CENTRE 
The general layout of the centre is presented Fig. 1 and 
Fig. 2. The accelerator, the beam lines, the treatment 
rooms and the control room are at the ground level 
(machine level). The doctor offices, treatment planning 
rooms, the scanners and NMR systems, as well as the 
accelerator conventional plant (power supplies, cooling 
system, technical offices etc.) are located at the first floor. 
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Figure 1: ETOILE layout (ground level). Scenario with a 
rotating gantry. 
 
2.1 Ion Production 
The technology of ion sources is well established to 
provide protons, helium, oxygen and carbon at the 
required intensities. Carbon ions are provided by an ECR 
source commercially available like SuperNanogan, whose 
main advantages are its excellent long term stability (±1% 
for intensity over 2 weeks with 200 µA C4+), its 
interchangeability and its reliability. Protons can be 
provided either by an ECR source or by a discharge 
source. H2+ or H3+ can be used to reduce the space charge 
effects. The required intensities are 125 µA for C4+, 
2.4 mA for protons and 1.2 mA for H2+. 
 
2.2 Injection System 
The injection system for ETOILE is based on that 
proposed for the GSI/Heidelberg project (HICAT) [3]. 
The injector of HICAT has been designed several years 
ago by the GSI team and the University of Franckfurt. 
This structure is as simple as possible (a single injector 
for several ion species), while providing a large range of 
adjustments, and is an optimized choice in terms of 
design and costs.  
 
Table 3: Injection parameters 
Energy 7 MeV/amu (proton to carbon) 
Emittance <1.2 π mm.mrad (total, normalized) 
∆p/p <±0.15% at 7MeV/amu 
Intensity 105 µA for  12C6+ 
1.38 mA for protons 
Injection time  33 µs  (16 turns) 
Repetition  < 1Hz 
Duty cycle 4 10-5 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: ETOILE layout (first floor). 
 
 
This injection system has also been chosen by the 
Italian and Swedish projects. It is composed of a low 
energy part (beam analysis, intensity adjustment, beam 
chopping), a RFQ, an IH-DTL and a medium energy 
beam line, including a stripper foil, where a debuncher is 
foreseen to reduce the momentum spread before injection 
in the synchrotron. 
 
2.3 Synchrotron 
Given the considerable amount of work and 
publications made by the PIMMS team, we will not give a 
detailed review of all the technical considerations which 
led to this optimized machine. We recall only some basic 
choices: multiturn injection (as proposed by CNA), 
transverse emittances equal over almost the whole range 
of extraction energies, use of a betatron core, invented 
and developed at SATURNE2 [5], to drive the beam to 
the resonance while keeping the optical parameters 
constant during extraction. The accelerating cavity is 
identical to that proposed in PIMMS and CNA and is 
based on a prototype tested in 1987 at SATURNE, and 
then transferred to CERN. 
Injection from the HICAT linac has been optimized [6], 
taking into account two limitations: the acceptance of the 
ring and the proton space charge at 7 MeV (PIMMS was 
designed for 20 MeV). In fact, the second limitation 
disappears because the number of protons per spill 
required by ETOILE is half of what is required for 
PIMMS. The MIMAS experience at SATURNE2 has 
demonstrated also that the sensitivity to field errors, 
clearly greater at 7 MeV than at 20 MeV, could be easily 
overcome. 
 
2.4 Beam Distribution 
A fishbone structure has been chosen. It is advantageous 
in terms of modularity, tuning and possibilities of 
extension, in particular if additional treatment rooms are 
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needed in the future. The whole distribution system is 
made of independent achromatic basic modules giving 
regular and periodic beam envelopes. The beam quality 
and some further treatment techniques can be tested at the 
downstream end of the fishbone. On Fig. 1, the two rooms 
located on the right are supplied by an horizontal fixed 
line, and the room on the left is supplied by a gantry. The 
scanning system is located at the extremity of each line, 
immediately after the last deflection dipole. Just after the 
synchrotron extraction section, a chicane will stop the 
beam delivery in case of interlock. 
 
2.5 Technical Devices 
A new C-type dipole has been studied for the 
distribution lines. All the other elements are identical or 
similar to those of PIMMS.  
The vacuum system is based on industrial type criteria 
to maximize reliability and efficiency: the desorption rate 
is 10-7 Pa.m.s-1, corresponding to a clean non-backed 
chamber; the synchrotron system is not baked but bake-
able, in event of accidental rise of the pressure; ion pumps 
are used in the ring, which require no maintenance. For 
example, the pressures are 5.10-7 Pa in the synchrotron 
and 10-5 Pa in the high energy beam lines. 
A large amount of beam diagnostics have been foreseen 
along the machine (intensity, position of the centre of 
gravity, transverse profiles, on-line dose control), in order 
to guarantee the quality, the reliability and the traceability 
of the operation.  
 
2.6 Control System 
Its design has been based over commercially available 
components. However, in view of the rate of development 
in this field, the definitive choices have to be made at the 
construction stage. The system can be divided into two 
parts. 
The accelerator control system is based on established 
solutions: VME for interfacing, VXI for the RF and 
EPICS for the software. 
The treatment control system, responsible for supplying 
the correct dose to the patient, and based on VME for the 
hardware interfaces, workstations for the operator 
interface and Ethernet for communications. 
The system will include the whole computing of the 
centre, including databases (accelerator and treatment 
data, archive, high volume storage and backup). 
3 BUILDING AND INFRASTUCTURE 
The lower floor (treatment) is dedicated to reception, 
treatment rooms and machine. The upper floor (service) 
is designed to house the medical services and auxiliary 
services (electrical distribution, power supplies, cooling, 
ventilation). In case of a network failure, a 250 kVA 
Uninterruptible Power Supply (UPS) has been foreseen, 
with 15 seconds independent operation and a return of 
300 kVA after a few seconds by a generating set. It is 
essential to protect sensitive equipment such as filaments 
of RF tubes and to back up data about treatment, 
radiological control, imaging and command/control. 
 
4 COST AND PLANNING 
The cost of the different subsystems is given table 3 for 
the two options (with and without gantry). The 
construction of the facility is planned over 5 years. A 6th 
year will be dedicated to machine testing, to validation of 
the treatment system and to administrative licensing for 
treatment. 
 
Table 3: Capital costs 
Capital costs 
(november 2001) 
without 
gantry 
(M) 
 
with 
gantry    
 (M) 
 
Production of ions, linear 
accelerator and low energy beam 
lines. 
 
8.83 
 
8.83 
Synchrotron 6.45 6.45 
Distribution + rasterscanning   4.68 10.21 
Control/computers 8.25 9 
Buiding, infrastructures, 
including project management 23.2 24.6 
Equipement for rooms 8.23 8.23 
Cost of development staff  15 15 
Contingencies 7% 5.22 5.74 
Total cost 79.86  88.06 
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